IRIS
ZANGHI', Mariangela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.741
NA - Nord America 2.043
AS - Asia 1.057
SA - Sud America 275
AF - Africa 32
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 6.151
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.013
RU - Federazione Russa 1.387
SG - Singapore 431
CN - Cina 352
SE - Svezia 313
IE - Irlanda 289
BR - Brasile 247
IT - Italia 227
HK - Hong Kong 116
DE - Germania 106
FR - Francia 95
UA - Ucraina 87
GB - Regno Unito 68
PL - Polonia 57
FI - Finlandia 50
VN - Vietnam 45
IN - India 33
BE - Belgio 23
CA - Canada 15
AR - Argentina 12
ZA - Sudafrica 12
MX - Messico 8
PK - Pakistan 8
BD - Bangladesh 7
CO - Colombia 7
IQ - Iraq 7
JP - Giappone 7
NL - Olanda 7
MA - Marocco 6
TR - Turchia 6
ES - Italia 5
UZ - Uzbekistan 5
AL - Albania 4
ET - Etiopia 4
JO - Giordania 4
NO - Norvegia 4
PH - Filippine 4
SA - Arabia Saudita 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
DZ - Algeria 3
ID - Indonesia 3
IR - Iran 3
LT - Lituania 3
MY - Malesia 3
AZ - Azerbaigian 2
BG - Bulgaria 2
BY - Bielorussia 2
EC - Ecuador 2
HR - Croazia 2
JM - Giamaica 2
KG - Kirghizistan 2
KZ - Kazakistan 2
NP - Nepal 2
OM - Oman 2
PE - Perù 2
RO - Romania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
AT - Austria 1
BH - Bahrain 1
BS - Bahamas 1
BZ - Belize 1
CI - Costa d'Avorio 1
CL - Cile 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EG - Egitto 1
EU - Europa 1
GE - Georgia 1
GT - Guatemala 1
IL - Israele 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LV - Lettonia 1
MU - Mauritius 1
NG - Nigeria 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
SI - Slovenia 1
TH - Thailandia 1
TN - Tunisia 1
Totale 6.151
Salva come PNG Salva come JPEG
Città #
Moscow 382
Dublin 287
Ashburn 264
Singapore 243
Chandler 212
Dallas 192
Nyköping 169
Jacksonville 166
Beijing 129
Hong Kong 116
San Jose 109
Ann Arbor 72
The Dalles 70
New York 58
Warsaw 55
Los Angeles 48
Dearborn 47
Messina 42
Medford 40
Princeton 40
Cambridge 39
Lauterbourg 35
Des Moines 34
Boardman 29
Munich 27
Brussels 23
São Paulo 23
Woodbridge 23
Buffalo 21
Tianjin 20
Lancaster 19
Ho Chi Minh City 17
San Mateo 17
Council Bluffs 15
Jinan 15
Wilmington 14
Pune 12
Frankfurt am Main 11
Hebei 11
Houston 10
Orem 10
Zhengzhou 10
Guangzhou 9
Nanjing 9
Rio de Janeiro 9
Taizhou 9
Chicago 8
Denver 8
Johannesburg 8
Shenyang 8
Turku 8
Brooklyn 7
Hanoi 7
London 7
Montreal 7
Seattle 7
Stockholm 7
Belo Horizonte 6
Chennai 6
Düsseldorf 6
Manchester 6
Nanchang 6
Ningbo 6
Redondo Beach 6
San Francisco 6
Amsterdam 5
Brasília 5
Hangzhou 5
Leawood 5
Monmouth Junction 5
Mumbai 5
Tokyo 5
Addis Ababa 4
Amman 4
Atlanta 4
Auburn Hills 4
Augusta 4
Boston 4
Haiphong 4
Jiaxing 4
Las Vegas 4
Medellín 4
Ribeirão Preto 4
Rome 4
Tashkent 4
Barnet 3
Belém 3
Bremen 3
Brockport 3
Changsha 3
Cuiabá 3
Curitiba 3
Genova 3
Goiânia 3
Guarulhos 3
Helsinki 3
Hillsboro 3
Joinville 3
João Pessoa 3
Karachi 3
Totale 3.474
Salva come PNG Salva come JPEG
Nome #
Linfoscintigrafia ascellare preoperatoria nel cancro della mammella. 326
A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): old successes and future perspectives 239
zd1839"iressa" in heavily pretreated patients with advaned/metastatic non-small cell lung cancer(NSCLC):assessment of tolerability and the clinical benefit 223
Androgen receptor (AR), E-cadherin, and Ki-67 as prognostic markers in triple-negative breast cancer (TNBC). 210
Epirubucin (EPI) and Paclitaxel (TAX) in advanced breast cancer.a phase II studyi 201
A PHASE II STUDY (21 DAY REGIMEN) OF GEMCITABINE AND CISPLATIN IN TRANSITIONAL CELL CARCINOMA OF BLADDER 186
Gemcitabine (GEM) and cisplatin (CIS) in advanced/metastatic transitional cell carcinoma (TCC) of bladder:phase II study 183
INCIDENZA DELL'ONCOTIPO POLMONARE NELLO STESSO TERRITORIO IN TRIENNI DIFFERENTI- 1983/84/85 E 1993/94/95. Eur. Jour. of Oncology Vol. 2, n° 4, 1997. 179
A new method for titration of oral transmucosal fentanyl citrate (OTFC) starting dose in cancer patients. 173
Beta=interferon in the treatment of 14 patie nts with advanced colorectal carcinoma. J Exp Pathol. 1987 Summer;3(4):603-5. No abstract available. PMID: 3454807 [PubMed - indexed for MEDLINE] 172
gemcitabine and pegylated liposomial doxorubicin in recurrent epithelial ovarian cancer (REOC).Preliminary report a phase II study 171
Gemcitabine (GEM) and cisplatin (Cis) in advanced/metastatic transitional cell carcinoma (TCC) of bladder: Phase II study 165
Second-line therapy in advanced non-small cell lung cancer: Cytotoxic agents or tyrosine kinase inhibitors? Our experience. 165
Etoposide, l-leucovorin and fluorouracil (ELF) regimen in metastatic gastric cancer: a phase II study. J Chemother. 1999 Feb;11(1):74-7. PMID: 10078785 [PubMed - indexed for MEDLINE] 164
Second line chemoterapy in patients with metastatic colorectal cancer(MCRC):our experience 162
ZD 1839 IRESSA IN HEAVILY PRETREATED PATIENTS WITH ADVANCED/METASTATIC NON SMALL CELL LUNG CANCER:ASSESSMENT OF TOLERABILITY AND CLINICAL BENEFIT 157
Etoposide, l-leucovorin and fluorouracil (ELF) regimen in metastatic gastric cancer: A phase II study 155
Correlation between serum magnesium levels and skin toxicity during cetuximab treatment in squamous cell carcinoma of head and neck cancer (SCCHN): the role of weekly intravenous magnesium supplementation. 155
Incidenza dell’oncotipo polmonare nello stesso territorio in trienni differenti 1983/84/85 e 1993/94/95. 150
Gemcitabine and liposomal doxorubicin in the salvage treatment of ovarian cancer: Updated results and long-term survival. 148
Dati preliminari sulla caratterizzazione molecolare dei casi di melanoma familiare di origine siciliana. 147
Dati preliminari sulla caratterizzazione molecolare dei casi di melanoma familiare di origine siciliana. 146
Role of Androgen Receptor (AR), Ki 67 and E-cadherin as prognostic markers in Triple Negative Breast Cancer (TNBC) 146
Predicting sensitivity of non small cell lung cancer to gefitinib and erlotinib: is there still a role for clinical factors ? 146
Dati preliminari sulla caratterizzazione molecolare dei casi di melanoma familiare di origine siciliana. 145
Third generation EGFR TKIs in EGFR-mutated NSCLC: Where are we now and where are we going 144
IL-33/IL-31 axis: A new pathological mechanism for epidermal growth factor receptor tyrosine kinase inhibitors-associated skin toxicity? 143
Impact of single-nucleotide polymorphisms in genes coding for folate pathway enzymes on efficacy/toxicity of gemcitabine and pemetrexed based therapy in advanced non small cell lung cancer (NSCLC): new prospectives for old markers. 138
NSCLC and HER2: between lights and shadows 131
LINFOSCINTIGRAFIA ASCELLARE PREOPERATORIA DEL CANCRO DELLA MAMMELLA. Acta Oncologica - Voi. XVI – n. 1, 1995. 125
Overview and new strategies in metastatic breast cancer (MBC) for treatment of tamoxifen-resistant patients. 124
May the istotype influence the response to pemetrexed in patients with non small cell lung cancer? Preliminary data of our clinical experience. 123
OUR EXPERIENCE ON THE EFFECTS OF TAMOXIFEN ON BLOOD COAGULATION IN PATIENTS OPERATED FOR BREAST CANCER Folia Oncologica vol.XIV-n.2-3 (Aprile-Settembre)-1991 119
Molecular and clinical analysis of predictive biomarkers to anti-EGFR inhibitors in metastatic colorectal cancer (mCRC): Interaction among early tumor shrinkage, skin toxicities, and RAS status. 118
Safety of trastuzumab, alone or in combination, in elderly patients with HER2-positive breast cancer: A 5-year case series. 113
PHASE II STUDY OF LIPOSOMAL DOXORUBICIN AND GEMCYTABINE IN THE TREATMENT OF RECURRENT OVARIAN CANCER 109
Induction chemotherapy to weekly paclitaxel concurrent with curative radiotherapy in stage IV (MO) unresectable head and neck squamous cell carcinoma: a dose escalation study 108
Safety of Zoledronic acid in bone metastatic breast cancer patients: A retrospective analysis. 99
Safety of trastuzumab-containing therapies in elderly women with metastatic breast cancer. 96
The risk of toxicities from trastuzumab, alone or in combination, in an elderly breast cancer population. 60
null 22
Totale 6.186
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.464
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.464
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202115 0 0 0 0 0 0 0 0 0 0 0 15
2021/2022332 4 57 6 10 6 1 25 9 3 86 40 85
2022/2023879 70 93 39 68 65 77 7 69 363 0 20 8
2023/2024227 20 42 7 24 12 81 14 14 0 4 0 9
2024/2025793 6 7 14 52 27 29 7 145 210 55 68 173
2025/20262.791 164 147 185 135 226 654 374 388 384 97 36 1
Totale 6.186